 |
市場調査レポート
商品コード
1478139
バイオ医療用加温・解凍装置の世界市場規模、シェア、成長分析、製品別、サンプル別 - 産業予測、2024～2031年Global Biomedical Warming and Thawing Devices Market Size, Share, Growth Analysis, By Product(Manual, Automatic), By Sample(Blood Products, Ovum/Embryo) - Industry Forecast 2024-2031 |
||||||
| バイオ医療用加温・解凍装置の世界市場規模、シェア、成長分析、製品別、サンプル別 - 産業予測、2024～2031年 |
|
出版日: 2024年05月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のバイオ医療用加温・解凍装置の市場規模は、2022年に3億7,500万米ドルとなり、2023年の4億785万米ドルから、2031年までには7億9,846万米ドルに成長し、予測期間（2024～2031年）のCAGRは8.76％で成長する見通しです。
世界のバイオ医療用加温・解凍装置市場は、近年著しい成長と進化を遂げています。これらの装置は、凍結生体サンプルの制御解凍・加温を容易にすることで、細胞培養、体外受精（IVF）、創薬、バイオバンクなど、さまざまな生物医学・生命科学アプリケーションにおいて重要な役割を果たしています。市場成長の重要な促進要因は、再生医療とバイオバンク研究の需要の増加です。再生医療分野の拡大に伴い、移植用に凍結保存された細胞や組織を正確かつ効率的に解凍・加温する必要性が高まっています。さまざまな生物学的サンプルを保管するバイオバンクもまた、回収時にサンプルの完全性を維持するためにこれらの装置に依存しています。さらに、COVID-19パンデミックは、ワクチン、血液製剤、診断試薬の保管と輸送におけるこれらの装置の重要性を浮き彫りにし、市場拡大にさらに貢献しています。技術の進歩により、解凍プロセスの精度とスピードが向上した革新的な自動加温・解凍装置が開発されています。これらの装置はまた、ユーザーフレンドリーなインターフェースとカスタマイズ可能な設定を特徴としており、研究者や臨床医にとってより魅力的なものとなっています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模予測
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要な投資の分析
- 主要な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
バイオ医療用加温・解凍装置の世界市場：製品別
- 市場概要
- 手動
- 自動
バイオ医療用加温・解凍装置の世界市場：サンプル別
- 市場概要
- 血液製品
- 卵子 / 胚
- 精液
- その他
バイオ医療用加温・解凍装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Helmer Scientific, Inc.（USA）
- Thermo Fisher Scientific Inc.（USA）
- Sarstedt AG & Co. KG（Germany）
- Boekel Scientific（USA）
- Barkey GmbH & Co. KG（Germany）
- BioCision, LLC（USA）
- Cardinal Health, Inc.（USA）
- Sartorius AG（Germany）
- Biocool（France）
- Helago-Celsis（Germany）
- CytoTherm（USA）
- Cole-Parmer Instrument Company, LLC（USA）
- Cyagen Biosciences（USA）
- Geno Technology, Inc.（USA）
- BrainBits LLC（USA）
- ADVANCED BIOLOGICAL MARKETING（USA）
- Hamilton Bonaduz AG（Switzerland）
- Deltalab S.L.（Spain）
- Boehringer Ingelheim（Germany）
- Arlington Scientific, Inc.（USA）
- Hamilton Company（USA）
- GE Healthcare（USA）
- ThawSTAR（USA）
- 3M（USA）
- Thomas Scientific（USA）
Global biomedical warming and thawing devices market size was valued at USD 375 million in 2022 and is poised to grow from USD 407.85 million in 2023 to USD 798.46 million by 2031, growing at a CAGR of 8.76% in the forecast period (2024-2031).
The global biomedical warming and thawing devices market has witnessed remarkable growth and evolution in recent years. These devices play a crucial role in various biomedical and life science applications, including cell culture, in vitro fertilization (IVF), drug discovery, and biobanking, by facilitating controlled thawing and warming of frozen biological samples. A significant driver of market growth is the increasing demand for regenerative medicine and biobanking research. With the expanding field of regenerative medicine, there is a growing need for precise and efficient thawing and warming of cryopreserved cells and tissues for transplantation. Biobanks, which store a wide array of biological samples, also rely on these devices to maintain sample integrity during retrieval. Additionally, the COVID-19 pandemic has underscored the importance of these devices in the storage and transportation of vaccines, blood products, and diagnostic reagents, further contributing to their market expansion. Technological advancements have led to the development of innovative and automated warming and thawing devices that offer enhanced precision and speed in the thawing process. These devices also feature user-friendly interfaces and customizable settings, making them more appealing to researchers and clinicians.
Top-down and bottom-up approaches were used to estimate and validate the size of the global biomedical warming and thawing devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biomedical Warming and Thawing Devices Market Segmental Analysis
The global biomedical warming and thawing devices market is segmented based on product, sample, end consumer, and place. By Product, the market is segmented into manual, and automatic. By sample, the market is segmented into Blood products, ovum/embryo, semen, and others. By end person, the market is segmented into hospitals, research laboratories, pharmaceutical industry, blood banks and transfusion centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Biomedical Warming and Thawing Devices Market
The increasing demand for biopharmaceutical products, including vaccines, antibodies, and cell-based therapies, has heightened the requirement for efficient and specialized warming and thawing devices. These devices play a crucial role in the safe and effective storage and processing of biopharmaceuticals, thus driving market growth.
Restraints in the Global Biomedical Warming and Thawing Devices Market
Biomedical warming and thawing devices can come with a hefty price tag for both purchase and installation. The substantial initial capital investment needed for these devices can pose a significant barrier, particularly for smaller healthcare facilities, research laboratories, and developing nations. This cost factor has the potential to limit market adoption.
Market Trends of the Global Biomedical Warming and Thawing Devices Market
One notable trend in the biomedical warming and thawing devices market is the increasing adoption of automated thawing solutions. Traditional thawing methods, such as manual water bath thawing, can be time-consuming and pose the risk of sample contamination. Automated thawing devices offer precision and efficiency in thawing various types of samples, including blood products, cellular therapies, and frozen tissues. These devices often feature advanced temperature control and monitoring capabilities, ensuring the preservation of sample integrity. The demand for automated thawing solutions is expected to continue rising as laboratories and healthcare facilities seek to streamline their sample preparation processes and reduce the risk of human errors.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Biomedical Warming and Thawing Devices Market By Product
- Market Overview
- Manual
- Automatic
Global Biomedical Warming and Thawing Devices Market By Sample
- Market Overview
- Blood Products
- Ovum/Embryo
- Semen
- and Others
Global Biomedical Warming and Thawing Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Helmer Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boekel Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Barkey GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioCision, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biocool (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Helago-Celsis (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CytoTherm (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cole-Parmer Instrument Company, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyagen Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Geno Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BrainBits LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ADVANCED BIOLOGICAL MARKETING (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Bonaduz AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Deltalab S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arlington Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ThawSTAR (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thomas Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
